Yonggao Mou

8PUBLICATIONS
25CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Molecular medicineGene expression (incl. microarray and other genome-wide approaches)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 29, 2026
An ambispective, observational real-world study of tumor-treating fields for treatment of Chinese patients with newly diagnosed or recurrent/progressive glioblastoma.

|Apr 15, 2026
Author Correction: A proteogenomic atlas of 1032 brain metastases identifies molecular subtypes, immune landscapes, and therapeutic vulnerabilities.

|Jan 26, 2026
A proteogenomic atlas of 1032 brain metastases identifies molecular subtypes, immune landscapes, and therapeutic vulnerabilities.

Zhenyu Yang, Shiyou Wei, Hao Duan

|Sep 12, 2025
Efficacy and Safety of T-DXd in HER2+ and Low/Zero Metastatic BCBM: A Retrospective Multicenter Real-World Study.

Qingru Zhou, Yuanyuan Li, Ni He

|Sep 30, 2024
Effect of the mRNA decapping enzyme scavenger (DCPS) inhibitor RG3039 on glioblastoma.

Hao Duan, Yuan Xie, Suwen Wu

|Aug 02, 2024
A brain cell atlas integrating single-cell transcriptomes across human brain regions.

Xinyue Chen, Yin Huang, Liangfeng Huang

Pageof 2

Frequent Collaborators

2 joint publications

Chaowei Zou

2 joint publications

Gao Zhang

2 joint publications

Gilberto Ka-Kit Leung

2 joint publications

Wanming Hu